Hints and tips:
Related Special Reports
...Linden Thomson, lead manager of the AXA IM Framlington Biotech fund, compared the vaccine companies with others that have had a standout year because of a single drug, such as Gilead with its hepatitis C...
...The jab’s variant formulation was approved by the US Food and Drug Administration earlier this month....
...The ruling came after Escobar Inc, the company set up by his brother, filed an application in 2021 with the European Union Intellectual Property Office (EUIPO) for registration of the word sign Pablo Escobar...
...Escobar Inc, a company set up by his brother Roberto, had filed an application in 2021 with the European Union Intellectual Property Office (EUIPO) to register “Pablo Escobar” as a trademark for goods and...
...Davis points to a long list of “more nimble” telehealth companies that also provide access to GLP-1 drugs, such as Noom, a direct-to-consumer weight-loss company with comparable subscription pricing to WW...
...Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the company’s credit rating was downgraded....
...Contributions from the company’s acquisitions — notably the $43bn purchase of cancer biotechnology company Seagen — have yet to move the needle....
...J&J’s medtech division has outstripped the growth of the company’s drugs and diagnostics business, generating $30.4bn in sales last year, or 35 per cent of group revenues....
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
...Investor worries about the impact of weight loss drugs on snack companies are overdone. Cigarette makers and oil and gas drillers are surviving bigger existential threats remarkably well....
...Roche plans to buy immunology company Telavant from Roivant Sciences and Pfizer for more than $7bn, as the drugmaker’s new chief executive seeks to replenish its drug pipeline....
...know: business Novo Nordisk announced a €1bn deal for a German biotech developing therapies to treat heart disease, as the Danish group seeks to branch out from its blockbuster diabetes and weight loss drugs...
...Eli Lilly’s strong performance in particular — its stock has almost doubled over the past year on the back of strong demand for new weight-loss drugs — highlights the fact that there are at least some themes...
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
..., the company said....
...Yet Merck recorded sales worth more than $6bn between 2021 and 2022, and the figure does not include sales in poorer markets where licensed companies make generic versions of the drug....
...MSD helped transform cancer care with its drug Keytruda, which harnessed the immune system to tackle tumours....
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
...“The drug companies are running to court to try to accomplish through the courts what they couldn’t get in Congress, which is block negotiation from happening.”...
...The drug could be used to replace bone marrow transplants....
...Mr Smith’s compensation barely made it past the Floridian cancer drugs testing company’s shareholders, with 52.8 per cent of votes in favour and 2.8 per cent abstaining. What’s happened since?...
...The Food and Drug Administration said on Thursday that it had issued marketing denial orders for six vaping products sold by BAT-owned RJ Reynolds Vapor Company under its Vuse Alto brand....
...Lecanemab was discovered by Swedish start-up BioArctic, which then partnered with the larger companies....
...The California-based pharmaceutical company agreed to the acquisition in December last year, winning a three-way race to add a new pipeline of drugs for rare autoimmune and inflammatory diseases....
...The US federal drug regulator has approved new Covid-19 boosters from Moderna and Pfizer, as it moves to contain infections from spreading more quickly in the US....
International Edition